Back | Next |
home / stock / sgmo / sgmo message board
Subject | By | Source | When |
---|---|---|---|
Sangamo participates in a conference call with Truist | MWM | investorshub | 12/11/2020 11:04:00 AM |
2022 $12 Calls looking good. | hitekmastr | investorshub | 12/11/2020 5:23:33 AM |
Thank you | tikotiko | investorshub | 12/11/2020 1:15:42 AM |
I loaded next weeks. The $15s I bought | MWM | investorshub | 12/11/2020 12:10:40 AM |
Nice! There are lotto calls which are my | MWM | investorshub | 12/11/2020 12:09:17 AM |
May I ask you what time period you | tikotiko | investorshub | 12/10/2020 9:46:13 PM |
LOL Ain't that the Truth my Friend! That's | DTGoody | investorshub | 12/10/2020 9:35:49 PM |
znewcar1: SGMO 52% v16,5M c15.65 f141M H15.69 solid run from EOD yesterday with a power hour push | znewcar1 | investorshangout | 12/10/2020 9:29:19 PM |
God I hope it is a buyout, I | MWM | investorshub | 12/10/2020 9:11:09 PM |
DT it got to $13 lol! Just took | MWM | investorshub | 12/10/2020 9:09:52 PM |
$SGMO | MWM | investorshub | 12/10/2020 9:08:15 PM |
I bought an ass load more of Calls | MWM | investorshub | 12/10/2020 8:56:53 PM |
Finally is right. I am glad I | tikotiko | investorshub | 12/10/2020 8:56:37 PM |
$SGMO something Major must be coming, Breakout above $14! | MWM | investorshub | 12/10/2020 8:43:01 PM |
SGMO Finally! | MWM | investorshub | 12/10/2020 8:39:05 PM |
whytestocks: $SGMO News Article - Sangamo Therapeutics Reports Business Highlights and Third Quarter | whytestocks | investorshangout | 11/04/2020 9:10:48 PM |
I agree! I have options that are going | DTGoody | investorshub | 07/16/2020 2:15:45 PM |
Took at starter almost a billion in cash | Fress | investorshub | 07/16/2020 8:25:42 AM |
Come on $SGMO Move up to around $13 | DTGoody | investorshub | 07/01/2020 11:48:18 PM |
znewcar1: SGMO 27% v10,0M c8.53 f115,9M preMH@10 O@~9 dip to S@8.2 then dragged out | znewcar1 | investorshangout | 02/29/2020 3:21:04 AM |
News, Short Squeeze, Breakout and More Instantly...
Sangamo Therapeutics Inc. Company Name:
SGMO Stock Symbol:
NASDAQ Market:
Sangamo Therapeutics Inc. Website:
2024-05-15 13:30:05 ET H.C. Wainwright analyst issues UNDERPERFORM recommendation for SGMO on May 15, 2024 11:01AM ET. The previous analyst recommendation was Underperform. SGMO was trading at $0.5901 at issue of the analyst recommendation. The overall analyst consensus ...
Showcased 20 presentations at the 27 th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting demonstrating progression of neurology-focused preclinical pipeline, including additional data from novel delivery capsid, STAC-BBB, that demonstrated industry-leading blood-brain barrie...
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today presented pre-clinical data showcasing its novel next-generation integrase technology engineered to enable large-scale genome editing. Building on Sangamo’s deep expertise in protein-DNA interactions derived from...